Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 953-863-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2015-05-26 to 2015-08-10
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed in accordance with standard test protocols (OECD 402) in a quality controlled laboratory. The study is valid according to criteria mentioned in the test protocols.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 402
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Nicotine
- EC Number:
- 200-193-3
- EC Name:
- Nicotine
- Cas Number:
- 54-11-5
- Molecular formula:
- C10H14N2
- IUPAC Name:
- 3-(1-methyl-2-pyrrolidinyl)pyridine
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or test system and environmental conditions:
- cross-reference: section 7.2.3
Test system
- Type of coverage:
- semiocclusive
- Preparation of test site:
- shaved
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- Preliminary study: 1000, 200, 50 and 5 mg/kg bw dose in females
Main study: 200, 100 and 50 mg/kg bw dose in females and 50 mg/kg bw dose in males - Duration of treatment / exposure:
- 24-hour exposure period
- Observation period:
- 14-day observation period
- Number of animals:
- Preliminary study: n=2 animals/dose
Main study: n=5 animals/sex/dose
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- erythema score
- Remarks on result:
- other: see "irritant/corrosive response data" and for detailed information please see "Any other information on results incl. tables".
- Irritation parameter:
- edema score
- Remarks on result:
- other: see "irritant/corrosive response data" and for detailed information please see "Any other information on results incl. tables".
- Irritant / corrosive response data:
- Dermal irritation symptoms were observed on the treatment site in both sexes.
In males treated with 50 mg/kg bw dose (group 1), very slight redness (score 1), well defined redness (score 2) and moderate to severe redness (score 3) was observed in one animal between Day 1 and Day 7. Moderate to severe redness (score 3) and severe redness (score 4) was detected in two animals between Day 1 and Day 7. Very slight redness (score 1) and well defined redness (score 2) was recorded in one animal between Day 1 and Day 7. Very slight redness (score 1) occurred in one animal between Day 1 and Day 5. Another sign as desquamation appeared in four animals on Day 6 and in one animal on Day 7. Crusting was recorded in four animals. It was observable between Day 7 and Day 14. Wound was found in two animals. It was observable between Day 11 and Day 14.
One male became free of skin irritation symptoms by Day 10.
In females treated with 50 mg/kg bw dose (group 1), very slight redness (score 1) was observed in two animals on Day 1. Well defined redness (score 2) and very slight redness (score 1) was detected in one animal on Day 1 and on Day 2, respectively. Moderate to severe redness (score 3) and well defined redness (score 2) was recorded in one animal on Day 1 and on Day 2, respectively.
Very slight redness (score 1) occurred in one animal treated with 100 mg/kg bw dose (group 2) on Day 1.
The survivor females became free of skin irritation symptoms by Day 3.
There was no oedema observed during the 14-day observation period in both sexes, but it was observable in females of group 2 and 3 on necropsy day.
Any other information on results incl. tables
Local symptoms (dermal irritation)
Oe:0 = No oedema
R:0 = No redness
R:1 = Very slight redness
R:2 = Well defined redness
R:3 = Moderate to severe redness
R:4 = Severe redness
C = Crusting; W = Wound; D = Desquamation
Males - Group 1 (50 mg/kg bw)
Animal No. | Day 1 | Day 3 | Day 7 | Day 14 |
#1 | R:1; Oe:0 | R:2; Oe:0 | R:1; Oe:0; D | R:0; Oe:0; C |
#2 | R:3; Oe:0 | R:4; Oe:0 | R:4; Oe:0; D; C | R:0; Oe:0; C |
#3 | R:1; Oe:0 | R:1; Oe:0 | R:2; Oe:0; D; C | R:0; Oe:0; W |
#4 | R:3; Oe:0 | R:3; Oe:0 | R:4; Oe:0; D; C | R:0; Oe:0; W |
#5 | R:1; Oe:0 | R:1; Oe:0 | R:0; Oe:0; D | R:0; Oe:0 |
Females - Group 1 (50 mg/kg bw)
Animal Number | Day 1 | Day 2 | Day 3 |
#1 | R:1; Oe:0 | R:0; Oe:0 | R:0; Oe:0 |
#2 | R:1; Oe:0 | R:0; Oe:0 | R:0; Oe:0 |
#3 | - | - | - |
#4 | R:2; Oe:0 | R:1; Oe:0 | R:0; Oe:0 |
#5 | R:3; Oe:0 | R:2; Oe:0 | R:0; Oe:0 |
Females - Group 2 (100 mg/kg bw)
Animal Number | Day 1 | Day 2 | Day 3 |
#1 | - | - | - |
#2 | - | - | - |
#3 | - | - | - |
#4 | R:1; Oe:0 | R:0; Oe:0 | R:0; Oe:0 |
#5 | - | - | - |
Females - Group 3 (200 mg/kg bw)
No data available due to lethality.
The survivor females were free of skin irritation symptoms from Day 4 until the end of observation period.
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 (irritant)
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Nicotine caused dermal irritation symptoms on the treatment site in both sexes in an acute toxicity study by dermal route in rabbits exposed to 3.0-3.2 mg/cm². No corrosion symptoms, according to CLP-regulation, Annex I, were observed, thus the substance is classified as Skin Irrit.2
- Executive summary:
Data for skin irritation potential were obtained from the acute dermal toxicity test (OECD 402, section 7.2.3.).
The test item caused dermal irritation symptoms on the treatment site in both sexes.
In males, very slight to severe erythema was observed between Day 1 and Day 7 and other signs as desquamation, crusting and wound were detected between Day 6 and the necropsy day, as well.
In females, very slight to severe erythema was recorded in 50 mg/kg bw dose group between treatment day and Day 2. Very slight to severe erythema and slight oedema was found in 100 mg/kg bw dose group between treatment day and Day 1. Moderate to severe erythema and slight to moderate oedema was detected in 200 mg/kg bw dose group on the treatment day.
Justification of the classification category (Skin Irrit. 2) is based on calculation of the amount of test substance per cm² and comparison to the test substance concentration of 80 mg/cm² employed in the EU B.4/OECD TG 404 (according to the recommended approach of testing and assessment strategy for skin corrosion/irritation in the Guidance on Information Requirements and Chemical Safety Assessment Chapter R.7a, Version 4.0, July 2015, Section R.7.2.6.2 (d)):
The back of animals was shaven (approximately 10 % area of the total body surface, approx. 36 cm²) 24 hours prior to the treatment. Group 1 (males) was treated with 50 mg nicotine per kg bw. The body weight range in main study at starting (males, group 1) was 2210 - 2310 g, thus the dose was 110.5-115.5 mg/36 cm². Therefore the animals were exposed to 3.0-3.2 mg/cm² nicotine. Compared to the standard test design treatment of 80 mg/cm², this small amount of nicotine per cm² resulted in clear dermal irritation symptoms on the treatment site in both sexes, especially in males: slight to severe redness, desquamation, crusting and wound. No corrosion symptoms (CLP,Annex I: 3.2.1.1. “irreversible damage of the skin […] typified by ulcers, bleeding, bloody scabs and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars”) were observed, thus the substance is classified as Skin Irrit. 2.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.